{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T21:27:37Z","timestamp":1789939657751,"version":"4.0.1"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"crossref","award":["2011.085.1"],"award-info":[{"award-number":["2011.085.1"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"crossref","award":["2011.085.2"],"award-info":[{"award-number":["2011.085.2"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["MA 1289\/7-1"],"award-info":[{"award-number":["MA 1289\/7-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.ejmech.2015.04.053","type":"journal-article","created":{"date-parts":[[2015,4,28]],"date-time":"2015-04-28T01:15:17Z","timestamp":1430183717000},"page":"164-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"special_numbering":"C","title":["New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids"],"prefix":"10.1016","volume":"97","author":[{"given":"Christoph","family":"Reiter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Fr\u00f6hlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maen","family":"Zeino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Marschall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanife","family":"Bahsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Leidenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Kappes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Hampel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Efferth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana B.","family":"Tsogoeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2015.04.053_bib1","first-page":"811","article-title":"Antimalaria studies on Qinghaosu","volume":"12","author":"Qinghaosu Antimalarial Coordinating Research Group","year":"1979","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.ejmech.2015.04.053_bib2","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.2174\/0929867033456710","article-title":"An over four millennium story behind Qinghaosu (artemisinin): a fantastic antimalarial drug from a traditional Chinese herb","volume":"10","author":"Li","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.053_bib3","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.cell.2011.08.024","article-title":"Artemisinin: discovery from the Chinese herbal Garden","volume":"146","author":"Miller","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2015.04.053_bib4","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1126\/science.3887571","article-title":"Qinghaosu (artemisinin): an antimalarial drug from China","volume":"228","author":"Klayman","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2015.04.053_bib5","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1242\/jeb.00653","article-title":"Antimalarial compounds: from bench to bedside","volume":"206","author":"Olliaro","year":"2003","journal-title":"J.\u00a0Exp. Biol."},{"key":"10.1016\/j.ejmech.2015.04.053_bib6","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.2174\/0929867043365233","article-title":"Recent advances in artemisinin and its derivatives as antimalarial and antitumor agents","volume":"11","author":"Jung","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.053_bib7","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1021\/ar100070k","article-title":"Heme as trigger and target for trioxane-containing antimalarial drugs","volume":"43","author":"Meunier","year":"2010","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2015.04.053_bib8","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1039\/B816679J","article-title":"Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents","volume":"39","author":"Chaturvedi","year":"2010","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2015.04.053_bib9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2174\/092986711794927748","article-title":"Road towards new antimalarials \u2013 overview of the strategies and their chemical progress","volume":"18","author":"Wu","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.053_bib10","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.2174\/092986711803414340","article-title":"Medicinal chemistry perspectives of trioxanes and tetraoxanes","volume":"18","author":"Kumar","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.053_bib11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1039\/c2md00277a","article-title":"Antimalarial peroxides: advances in drug discovery and design","volume":"3","author":"Slack","year":"2012","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.ejmech.2015.04.053_bib12","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/np50096a007","article-title":"Cytotoxicity of artemisinin-related endoperoxides to ehrlich ascites tumor cells","volume":"56","author":"Woerdenbag","year":"1993","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2015.04.053_bib13","first-page":"196","article-title":"Detection of apoptosis in KG-1a leukemic cells treated with investigational drugs","volume":"46","author":"Efferth","year":"1996","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejmech.2015.04.053_bib14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1021\/np9605495","article-title":"Stereochemistry-dependent cytotoxicity of some artemisinin derivatives","volume":"60","author":"Beekman","year":"1997","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2015.04.053_bib15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1043-6618(03)00107-5","article-title":"Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in\u00a0vitro","volume":"48","author":"Chen","year":"2003","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2015.04.053_bib16","first-page":"2277","article-title":"Artemisinin induces apoptosis in human cancer cells","volume":"24","author":"Singh","year":"2004","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejmech.2015.04.053_bib17","first-page":"2153","article-title":"Artemisinin: an alternative treatment for oral squamous cell carcinoma","volume":"24","author":"Yamachika","year":"2004","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejmech.2015.04.053_bib18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00280-003-0751-4","article-title":"Antimalarial dihydroartemisinin also inhibits angiogenesis","volume":"53","author":"Chen","year":"2004","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejmech.2015.04.053_bib19","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.freeradbiomed.2004.06.023","article-title":"Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron","volume":"37","author":"Efferth","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2015.04.053_bib20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.drup.2005.04.003","article-title":"Mechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy","volume":"8","author":"Efferth","year":"2005","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.ejmech.2015.04.053_bib21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1055\/s-2007-967138","article-title":"Willmar Schwabe Award 2006: antiplasmodial and antitumor activity of artemisinin - from bench to bedside","volume":"73","author":"Efferth","year":"2007","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2015.04.053_bib22","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s10637-011-9676-7","article-title":"The redox antimalarial dihydroartemisinin targets human metastatic melanoma cells but not primary melanocytes with induction of NOXA-dependent apoptosis","volume":"30","author":"Cabello","year":"2012","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.ejmech.2015.04.053_bib23","first-page":"247597","article-title":"Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug","volume":"2012","author":"Crespo-Ortiz","year":"2012","journal-title":"J.\u00a0Biomed. Biotechnol."},{"key":"10.1016\/j.ejmech.2015.04.053_bib24","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s10637-012-9873-z","article-title":"Development of artemisinin compounds for cancer treatment","volume":"31","author":"Lai","year":"2013","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.ejmech.2015.04.053_bib25","first-page":"271","article-title":"The immunologic and antiviral effect of qinghaosu","volume":"2","author":"Qian","year":"1982","journal-title":"J.\u00a0Tradit. Chin. Med."},{"key":"10.1016\/j.ejmech.2015.04.053_bib26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.antiviral.2005.07.005","article-title":"Effect of artemisinin\/artesunate as inhibitors of hepatitis B virus production in an \u201cin\u00a0vitro\u201d replicative system","volume":"68","author":"Romero","year":"2005","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2015.04.053_bib27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbrc.2006.07.014","article-title":"Hemin potentiates the anti-hepatitis C virus activity of the antimalarial drug artemisinin","volume":"348","author":"Paeshuyse","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2015.04.053_bib28","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1055\/s-2006-947198","article-title":"Antiviral effect of artemisinin from Artemisia annua against a model member of the Flaviviridae family, the bovine viral diarrhoea virus (BVDV)","volume":"72","author":"Romero","year":"2006","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2015.04.053_bib29","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/591195","article-title":"The antiviral activities of artemisinin and artesunate","volume":"47","author":"Efferth","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2015.04.053_bib30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/aps.2008.5","article-title":"Natural products as promising drug candidates for the treatment of hepatitis B and C","volume":"30","author":"Wohlfarth","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2015.04.053_bib31","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1128\/MMBR.60.2.301-315.1996","article-title":"Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy","volume":"60","author":"Meshnick","year":"1996","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2015.04.053_bib32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1054-3589(08)60952-7","article-title":"Antimalarial activity of artemisinin (qinghaosu) and related trioxanes: mechanism(s) of action","volume":"37","author":"Cumming","year":"1997","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.ejmech.2015.04.053_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bcp.2004.03.003","article-title":"Oxidative stress response of tumor cells: microarray-based comparison between artemisinins and anthracyclines","volume":"68","author":"Efferth","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2015.04.053_bib34","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1089\/ars.2009.2541","article-title":"Redox-directed cancer therapeutics: molecular mechanisms and opportunities","volume":"11","author":"Wondrak","year":"2009","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.ejmech.2015.04.053_bib35","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3390\/molecules15031705","article-title":"The molecular mechanism of action of artemisinin \u2013 the debate continues","volume":"15","author":"O'Neill","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2015.04.053_bib36","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1039\/c2mb05437j","article-title":"Bioinformatic and experimental fishing for artemisinin-interacting proteins from human nasopharyngeal cancer cells","volume":"8","author":"Eichhorn","year":"2012","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.ejmech.2015.04.053_bib37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bcp.2012.10.006","article-title":"Molecular interaction of artemisinin with translationally controlled tumor protein (TCTP) of Plasmodium falciparum","volume":"85","author":"Eichhorn","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2015.04.053_bib38","doi-asserted-by":"crossref","first-page":"e81783","DOI":"10.1371\/journal.pone.0081783","article-title":"Artemisinin analogues as potent inhibitors of in\u00a0Vitro Hepatitis C Virus replication","volume":"8","author":"Obeid","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2015.04.053_bib39","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1056\/NEJMc0805011","article-title":"Evidence of artemisinin-resistant malaria in Western Cambodia","volume":"359","author":"Noedl","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2015.04.053_bib40","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2015.04.053_bib41","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S1473-3099(12)70181-0","article-title":"Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study","volume":"12","author":"Amaratunga","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2015.04.053_bib42","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/S0140-6736(12)60484-X","article-title":"Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study","volume":"379","author":"Pyae Phyo","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2015.04.053_bib43","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1039\/b204748a","article-title":"Hybrid systems through natural product leads: an approach towards new molecular entities","volume":"31","author":"Mehta","year":"2002","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2015.04.053_bib44","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1002\/anie.200200553","article-title":"Natural product hybrids as new leads for drug discovery","volume":"42","author":"Tietze","year":"2003","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2015.04.053_bib45","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.copbio.2004.09.002","article-title":"Natural products as a hunting ground for combinatorial chemistry","volume":"15","author":"Ganesan","year":"2004","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.ejmech.2015.04.053_bib46","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2533\/chimia.2006.841","article-title":"Natural product hybrids","volume":"60","author":"Gademann","year":"2006","journal-title":"Chimia"},{"key":"10.1016\/j.ejmech.2015.04.053_bib47","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ar7000843","article-title":"Hybrid molecules with a dual mode of action: dream or reality?","volume":"41","author":"Meunier","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2015.04.053_bib48","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2174\/138955710791608280","article-title":"Recent progress in the development of synthetic hybrids of natural or unnatural bioactive compounds for medicinal chemistry","volume":"10","author":"Tsogoeva","year":"2010","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.053_bib49","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.1002\/anie.200604697","article-title":"Evidence for a common non-heme chelatable-iron-dependent activation mechanism for semisynthetic and synthetic endoperoxide antimalarial drugs","volume":"46","author":"Stocks","year":"2007","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2015.04.053_bib50","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.bmc.2008.12.017","article-title":"Synthesis and biological evaluation of extraordinarily potent C-10 carba artemisinin dimers against P. falciparum malaria parasites and HL-60 cancer cells","volume":"17","author":"Chadwick","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.053_bib51","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1021\/jm100404t","article-title":"Cytotoxicity of artesunic acid Homo- and Heterodimer molecules toward sensitive and multidrug-resistant CCRF-CEM leukemia cells","volume":"53","author":"Horwedel","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.053_bib52","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.1016\/j.bmcl.2010.09.130","article-title":"Artemisinin-quinoline hybrid-dimers: synthesis and in\u00a0vitro antiplasmodial activity","volume":"20","author":"Lombard","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.04.053_bib53","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1248\/cpb.59.984","article-title":"Design, synthesis and antitumor activity of novel artemisinin derivatives using hybrid approach","volume":"59","author":"Xie","year":"2011","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2015.04.053_bib54","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1248\/cpb.59.1471","article-title":"Discovery of artemisinin-glycolipid hybrids as anti-oral cancer agents","volume":"59","author":"Ricci","year":"2011","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2015.04.053_bib55","doi-asserted-by":"crossref","first-page":"e24334","DOI":"10.1371\/journal.pone.0024334","article-title":"An artemisinin-derived dimer has highly potent anti-cytomegalovirus (CMV) and anti-cancer activities","volume":"6","author":"He","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2015.04.053_bib56","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1128\/AAC.00519-12","article-title":"artemisinin-derived dimer diphenyl phosphate is an irreversible inhibitor of human cytomegalovirus replication","volume":"56","author":"He","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2015.04.053_bib57","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1016\/j.bmc.2012.07.015","article-title":"New artesunic acid homodimers: potent reversal agents of multidrug resistance in leukemia cells","volume":"20","author":"Reiter","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.053_bib58","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1021\/jm970401y","article-title":"Synthesis and antimalarial activity in\u00a0vitro and in\u00a0vivo of a new ferrocene-chloroquine analogue","volume":"40","author":"Biot","year":"1997","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.053_bib59","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1051\/parasite\/2011183207","article-title":"The antimalarial Ferroquine: from bench to clinic","volume":"18","author":"Biot","year":"2011","journal-title":"Parasite"},{"key":"10.1016\/j.ejmech.2015.04.053_bib60","doi-asserted-by":"crossref","first-page":"783","DOI":"10.4155\/fmc.12.26","article-title":"Ferrocene-based antimalarials","volume":"4","author":"Roux","year":"2012","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.053_bib61","doi-asserted-by":"crossref","first-page":"7690","DOI":"10.1002\/anie.201303690","article-title":"The Ferroquine antimalarial conundrum: redox activation and reinvasion inhibition","volume":"52","author":"Dubar","year":"2013","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2015.04.053_bib62","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0022-328X(97)00086-7","article-title":"Facile route to ferrocifen, 1-[4-(2-dimethylaminoethoxy)]-1-(phenyl-2-ferrocenyl-but-1-ene), first organometallic analogue of tamoxifen, by the McMurry reaction","volume":"541","author":"Top","year":"1997","journal-title":"J.\u00a0Organomet. Chem."},{"key":"10.1016\/j.ejmech.2015.04.053_bib63","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0022-328X(01)00953-6","article-title":"Studies on organometallic selective estrogen receptor modulators. (SERMs) dual activity in the hydroxy-ferrocifen series","volume":"637","author":"Top","year":"2001","journal-title":"J.\u00a0Organomet. Chem."},{"key":"10.1016\/j.ejmech.2015.04.053_bib64","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.2174\/0929867043364487","article-title":"The first organometallic selective estrogen receptor modulators (SERMs) and their relevance to breast cancer","volume":"11","author":"Jaouen","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.053_bib65","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/anie.200502925","article-title":"Ferrocene-mediated proton-coupled electron transfer in a series of ferrocifen-type breast cancer drug candidates","volume":"45","author":"Hillard","year":"2006","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2015.04.053_bib66","doi-asserted-by":"crossref","first-page":"716","DOI":"10.2533\/chimia.2007.716","article-title":"Ferrocifens and ferrocifenols as new potential weapons against breast cancer","volume":"61","author":"Nguyen","year":"2007","journal-title":"Chimia"},{"key":"10.1016\/j.ejmech.2015.04.053_bib67","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1016\/j.jinorgbio.2008.07.014","article-title":"Evaluation of cytotoxic properties of organometallic ferrocifens on melanocytes, primary and metastatic melanoma cell lines","volume":"102","author":"Michard","year":"2008","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2015.04.053_bib68","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1021\/jm500246h","article-title":"Organometallic nucleoside analogues with ferrocenyl linker groups: synthesis and cancer cell line studies","volume":"57","author":"Nguyen","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.053_bib69","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1016\/S0968-0896(00)00206-6","article-title":"Novel ferrocenic artemisinin derivatives: synthesis, in\u00a0vitro antimalarial activity and affinity of binding with ferroprotoporphyrin IX","volume":"8","author":"Delhaes","year":"2000","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.053_bib70","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1021\/jm100117e","article-title":"Trioxaferroquines as new hybrid antimalarial drugs","volume":"53","author":"Bellot","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.053_bib71","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ejmech.2014.01.043","article-title":"Synthesis and study of cytotoxic activity of 1,2,4-trioxane- and egonol-derived hybrid molecules against Plasmodium falciparum and multidrug-resistant human leukemia cells","volume":"75","author":"Reiter","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.053_bib72","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0960-894X(01)81060-X","article-title":"A\u00a0concise synthesis of 12-(3'-hydroxy-n-propyl)-deoxoartemisinin","volume":"1","author":"Jung","year":"1991","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.04.053_bib73","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1055\/s-1992-21384","article-title":"Efficient preparation of novel qinghaosu (Artemisinin) derivatives: conversion of qinghao (Artemisinic) acid into deoxoqinghaosu derivatives and 5-Carba-4-deoxoartesunic acid","author":"Haynes","year":"1992","journal-title":"Synlett"},{"key":"10.1016\/j.ejmech.2015.04.053_bib74","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.3987\/COM-93-6430","article-title":"An unusual acid-catalyzed rearrangement of 1,2,4-trioxanes","volume":"36","author":"Pu","year":"1993","journal-title":"Heterocycles"},{"key":"10.1016\/j.ejmech.2015.04.053_bib75","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1021\/jm00004a007","article-title":"Synthesis and antimalarial activities of 12beta-allyldeoxoartemisinin and its derivatives","volume":"38","author":"Pu","year":"1995","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.053_bib76","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1039\/b104340b","article-title":"Optimisation of the allylsilane approach to C-10 deoxo carba analogues of dihydroartemisinin: synthesis and in\u00a0vitro antimalarial activity of new, metabolically stable C-10 analogues","author":"O'Neill","year":"2001","journal-title":"J.\u00a0Chem. Soc. Perkin Trans. I"},{"key":"10.1016\/j.ejmech.2015.04.053_bib77","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1021\/jm9005934","article-title":"Malaria-infected mice live until at least day 30 after a new monomeric trioxane combined with mefloquine are administered together in a single low oral dose","volume":"52","author":"Woodard","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.053_bib78","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1021\/jm020461q","article-title":"Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers with high stability and efficacy","volume":"46","author":"Posner","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.053_bib79","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1021\/jm0303711","article-title":"Anticancer and antimalarial efficacy and safety of artemisinin-derived trioxane dimers in rodents","volume":"47","author":"Posner","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.053_bib80","doi-asserted-by":"crossref","first-page":"7836","DOI":"10.1021\/jm060803i","article-title":"Biological mechanisms of action of novel C-10 non-acetal trioxane dimers in prostate cancer cell lines","volume":"49","author":"Alagbala","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.053_bib81","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.bmcl.2005.11.074","article-title":"Antiangiogenic activity of deoxoartemisinin derivatives on chorioallantoic membrane","volume":"16","author":"Jung","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.04.053_bib82","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1021\/jm070149m","article-title":"Malaria-infected mice are cured by a single dose of novel artemisinin derivatives","volume":"50","author":"Posner","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.053_bib83","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1021\/jm701168h","article-title":"Malaria-infected mice are cured by oral administration of new artemisinin derivatives","volume":"51","author":"Posner","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.053_bib84","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1021\/jm801484v","article-title":"Malaria-infected mice are cured by a single oral dose of new dimeric trioxane sulfones which are also Selectively and Powerfully cytotoxic to cancer cells","volume":"52","author":"Rosenthal","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.053_bib85","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1016\/j.bmcl.2010.08.013","article-title":"Concise synthesis and antiangiogenic activity of artemisinin\u2013glycolipid hybrids on chorioallantoic membranes","volume":"20","author":"Ricci","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.04.053_bib86","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1021\/jm030974c","article-title":"Antimalarial and antitumor evaluation of novel C-10 non-acetal dimers of 10beta-(2-hydroxyethyl)deoxoartemisinin","volume":"47","author":"Jeyadevan","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.04.053_bib87","unstructured":"CCDC-994084 and CCDC-994085 contain the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk\/data_request\/cif."},{"key":"10.1016\/j.ejmech.2015.04.053_bib88","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1055\/s-0032-1327896","article-title":"Phytochemical analysis and cytotoxicity towards multidrug-resistant leukemia cells of essential oils derived from Lebanese medicinal plants","volume":"78","author":"Saab","year":"2012","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2015.04.053_bib89","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1128\/AAC.44.6.1588-1597.2000","article-title":"Recombinant green fluorescent protein-expressing human cytomegalovirus as a tool for screening antiviral agents","volume":"44","author":"Marschall","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2015.04.053_bib90","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1128\/AAC.05908-11","article-title":"In\u00a0vitro evaluation of the activities of the novel anticytomegalovirus compound AIC246 (letermovir) against herpesviruses and other human pathogenic viruses","volume":"56","author":"Marschall","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2015.04.053_bib91","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.antiviral.2005.10.003","article-title":"The anti-malaria drug artesunate inhibits replication of cytomegalovirus in\u00a0vitro and in\u00a0vivo","volume":"69","author":"Kaptein","year":"2006","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2015.04.053_bib92","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.antiviral.2011.07.018","article-title":"The unique antiviral activity of artesunate is broadly effective against human cytomegaloviruses including therapy-resistant mutants","volume":"92","author":"Chou","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2015.04.053_bib93","first-page":"6793","article-title":"Susceptibility of multidrug-resistant human leukemia cell lines to human Interleukin 2-activated Killer cells","volume":"50","author":"Kimmig","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2015.04.053_bib94","doi-asserted-by":"crossref","first-page":"8987","DOI":"10.1158\/0008-5472.CAN-04-1978","article-title":"Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes","volume":"64","author":"Gillet","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2015.04.053_bib95","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1158\/1078-0432.CCR-07-4525","article-title":"Prediction of Broad spectrum resistance of Tumors towards anticancer drugs","volume":"14","author":"Efferth","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2015.04.053_bib96","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1046\/j.1432-1327.2000.01606.x","article-title":"Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity","volume":"267","author":"O'Brien","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ejmech.2015.04.053_bib97","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1055\/s-0031-1280319","article-title":"Antibacterial activity and cytotoxicity of selected Egyptian medicinal plants","volume":"78","author":"Kuete","year":"2012","journal-title":"Planta Med."},{"key":"10.1016\/j.ejmech.2015.04.053_bib98","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2307\/3280287","article-title":"Synchronization of Plasmodium falciparum erythrocytic stages in culture","volume":"65","author":"Lambros","year":"1979","journal-title":"J.\u00a0Parasitol."},{"key":"10.1016\/j.ejmech.2015.04.053_bib99","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","article-title":"Simple and inexpensive fluorescence-based technique for highthroughput antimalarial drug screening","volume":"48","author":"Smilkstein","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2015.04.053_bib100","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/AAC.00916-10","article-title":"Genetic predisposition favors the acquisition of stable artemisinin resistance in malaria parasites","volume":"55","author":"Beez","year":"2011","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523415300179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523415300179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T11:50:15Z","timestamp":1598961015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523415300179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":100,"alternative-id":["S0223523415300179"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2015.04.053","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2015.04.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}